DCF — CENTRAL MONTANA MEDICAL CENTER
Enterprise Value: $-79.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-79.9M
Enterprise Value
$-25.1M
PV of Cash Flows
$-54.8M
PV of Terminal Value
$-88.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $44.3M | $-5.1M | -11.0% | $-7.0M | $-6.3M |
| Year 2 | $45.6M | $-4.8M | -10.0% | $-6.7M | $-5.5M |
| Year 3 | $47.0M | $-4.4M | -9.0% | $-6.4M | $-4.8M |
| Year 4 | $48.4M | $-4.3M | -9.0% | $-6.4M | $-4.4M |
| Year 5 | $49.9M | $-4.3M | -9.0% | $-6.5M | $-4.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-79.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$43.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11961761042517075
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5